Alzheimer’s disease (AD) is a progressive neurodegenerative pathology defined as the accumulation of hyperphosphorylated tau (p-tau) protein aggregates within neurons and extracellular amyloid-beta (Aβ), a product of amyloid precursor protein (APP) processing [1]. Here, MAPT is linked to Alzheimer disease.